Results 101 to 110 of about 10,088 (191)

STUDY TO KNOW THE RIFAXIMIN EFFICACY IN HEPATIC ENCEPHALOPATHY PREVENTION IN CIRRHOSIS OF LIVER

open access: yes, 2018
Objective: To evaluate the safety and efficacy of Rifaximin in patients with liver cirrhosis to prevent hepatic encephalopathy recurrence according to lactulose alone. Study design: Randomized controlled trial.
Dr.Fatima Munir, Dr.Madiha Waseem, Dr.Muhammad Umair Mazhar
core   +1 more source

Eradication of Helicobacter pylori: are rifaximin-based regimens effective?

open access: yes, 2006
Rifaximin is a non-absorbed semisynthetic rifamycin derivative with a broad spectrum of antibacterial activity including Gram-positive and Gram-negative bacteria, both aerobes and anaerobes.
Gasbarrini, Antonio   +1 more
core  

The susceptibility of helicobacter pylori to the rifamycin, rifaximin

open access: yes, 1995
Forty strains of Helicobacter pylori had an MIC50 of 4 mg/L of the non-absorbably antibiotic, rifaximin. Neither synergy nor antagonism was demonstrated when the drug was combined with ampicillin, metronidazole and omeprazole and the rate of spontaneous ...
Menegatti M.   +3 more
core   +1 more source

Rifaximin suspension for the eradication of Helicobacter pylori

open access: yes, 1997
The in vitro sensitivity- of Helicobacter pylori to rifaximin, a new rifamycin antibiotic, was evaluated in 40 clinical isolates by the agar dilution method.
Biasco G.   +37 more
core   +1 more source

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

open access: yesDrug Design, Development and Therapy, 2014
Corrado Blandizzi,1 Giuseppe Claudio Viscomi,2 Carmelo Scarpignato31Division of Pharmacology and Chemotherapy, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 2Research and Development Division, Alfa Wassermann SpA, Bologna ...
Blandizzi C, Viscomi GC, Scarpignato C
doaj  

Effects of rifaximin on the fecal microbiota of healthy dogs: a pilot study. [PDF]

open access: yesFront Vet Sci
Harada H   +7 more
europepmc   +1 more source

Rifaximin Versus Placebo for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

open access: yesCureus
Alqurain AA   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy